BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26280242)

  • 1. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?
    Goh BK; Tan DM; Chan CY; Lee SY; Lee VT; Thng CH; Low AS; Tai DW; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2015 Sep; 112(4):366-71. PubMed ID: 26280242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative platelet-to-lymphocyte ratio improves the performance of the international consensus guidelines in predicting malignant pancreatic cystic neoplasms.
    Goh BK; Teo JY; Allen JC; Tan DM; Chan CY; Lee SY; Tai DW; Thng CH; Cheow PC; Chow PK; Ooi LL; Chung AY
    Pancreatology; 2016; 16(5):888-92. PubMed ID: 27421563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
    Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM
    J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Gemenetzis G; Bagante F; Griffin JF; Rezaee N; Javed AA; Manos LL; Lennon AM; Wood LD; Hruban RH; Zheng L; Zaheer A; Fishman EK; Ahuja N; Cameron JL; Weiss MJ; He J; Wolfgang CL
    Ann Surg; 2017 Aug; 266(2):339-345. PubMed ID: 27631774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
    Fan W; Zhang Y; Wang Y; Yao X; Yang J; Li J
    PLoS One; 2015; 10(3):e0119312. PubMed ID: 25742141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?
    Kim EY; Lee JW; Yoo HM; Park CH; Song KY
    Ann Surg Oncol; 2015 Dec; 22(13):4363-70. PubMed ID: 25805235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
    Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
    Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
    Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms.
    Watanabe Y; Niina Y; Nishihara K; Okayama T; Tamiya S; Nakano T
    Acta Chir Belg; 2018 Aug; 118(4):239-245. PubMed ID: 29334845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
    Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
    Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.
    Goh BK; Tan DM; Thng CH; Lee SY; Low AS; Chan CY; Wong JS; Lee VT; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
    Ann Surg Oncol; 2014 Jun; 21(6):1919-26. PubMed ID: 24504924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.
    Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R
    J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer.
    Azab B; Mohammad F; Shah N; Vonfrolio S; Lu W; Kedia S; Bloom SW
    Cancer Biomark; 2014; 14(5):303-12. PubMed ID: 25171472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of preoperative CA19-9 combined with platelet-to-lymphocyte ratio in predicting invasive malignancy in intraductal papillary mucinous neoplasms].
    Li JA; Han X; Fang Y; Zhang L; Lou WH; Xu XF; Wu WC; Kuang TT; Wang DS; Rong YF
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):170-175. PubMed ID: 30861644
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Xie X; Luo KJ; Hu Y; Wang JY; Chen J
    Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.